HORIBA at the forefront of innovation and technological advancements

The HORIBA Group has been committed to contributing to social progress and the realization of a sustainable future for all through the development of technologies. Measurement and analysis are fundamental to the advancement of science and technology. Our mission is to explore cutting-edge measurement and analysis solutions that lead to significant discoveries and enable breakthroughs for the realization of a sustainable society.

HORIBA has more than 40+ years of experience in the healthcare industry and has reached an international reputation with support of its high standards in terms of innovation. With its flexible production units and pioneering R&D centers, HORIBA is always a step ahead in both research and development of the products, always responding to market needs. HORIBA develops solutions, which are adapted to its customers’ demands, and anticipates their needs.

HORIBA provides a comprehensive line of hematology, hemostasis, and clinical chemistry solutions (including analyzers, reagents, and consumables) for use in in-vitro diagnostics. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics, and university hospitals. Drawing on its extensive experience and its strong reputation in hematology, HORIBA strives to become a complete IVD player in the industry.

Our marketing strategy for the year has been to enhance customer delight by disseminating scientific knowledge through various programs while focusing on product diversification. We are continuously working toward expanding our product portfolio, digitizing our products with the support of artificial intelligence (AI), making our services remotely accessible, and we have recently launched multiple new products. We are also expanding our reach across the country and growing presence in the SAARC market through multiple initiatives and scientific programs.

HORIBA India is committed to bringing products of indigenous make to customers while ensuring HORIBA’s global product standards and quality. HORIBA has invested in manufacturing facilities in India and these investments contribute to the Make in India of the Government of India’s (GOI) push toward industrial development, economic growth, more job creation, and self-sustainability, i.e., Atmanirbhar Bharat.

One such state-of-the-art manufacturing facility was recently inaugurated at Butibori, Nagpur, which is spread across an area of 12 acres. This one-of-a-kind facility comprises of manufacturing, refurbishment, central warehouse, an international training center, HORIBA Experience Zone, and HORIBA India Technical Institute (HITI). We have started manufacturing analyzers in the clinical chemistry segment at this facility.

• Yumizen CA40, a semi-automated clinical chemistry analyzer with the facility to perform chemistry, immunoturbidimetry, and coagulation tests (PT and APTT). This analyzer is an asset for any laboratory, offering several benefits that can help to improve the efficiency, accuracy, and affordability of healthcare. It is ideal for small and mid-sized laboratories and can also work as backup chemistry support for all laboratories with high workloads.
• Yumizen C150, a new bench-top automated clinical chemistry analyzer with a throughput of 200 tests per hour. It has a unique compact design with inbuilt laundry and cooling facilities for reagents, making it ideal for space-constrained laboratories along with unique software features, such as user-defined reflex action and unlimited patient result storage capacity. This system would be ideal for small and mid-sized laboratories.
• Yumizen E60, a user-friendly and reliable electrolyte analyzer, ideal for medium- to high-volume laboratories and hospitals. It allows measurement of specific ions, accurately and precisely, supporting fast diagnosis. It has a throughput of 60 samples per hour, a 5” color LCD touchscreen display, and a storage capacity of 10,000 patient results.

The new emerging, cutting-edge technologies in medical healthcare and life sciences are expected to redefine the entire healthcare ecosystem. India is one of the fastest-growing life sciences markets in the world and the sector is poised to see multi-fold growth by 2030. Over the past decades, the Indian life sciences sector has witnessed exponential growth in terms of broadening scope, new research and development and deepening of capabilities across the industry value chain. In recent years, HORIBA has also expanded into the field of life science by uniting with scientific analysis equipment technology.

HORIBA will develop and deliver innovative analytical and automation solutions, combining state-of-the-art, optical, electrochemical, Raman spectroscopy, and x-ray fluorescence technologies, with core competencies in sampling, engineering, and data science. HORIBA will contribute to breakthroughs in drug development and manufacturing, leading to the adoption of new technologies, and contributing to healthier, more affordable and more equitable health care for all.